AI assistant
Sending…
Esperion Therapeutics, Inc. — Director's Dealing 2021
Nov 1, 2021
32771_dirs_2021-11-01_453d4c4f-48e0-42fb-be5d-96597ecbeec2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Esperion Therapeutics, Inc. (ESPR)
CIK: 0001434868
Period of Report: 2021-10-28
Reporting Person: Fischer Seth H. Z. (Director)
More from Esperion Therapeutics, Inc.
Merger & Acquisition
2026
Jun 8
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 1
Interim / Quarterly Report
2026
May 8
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Mar 17
Regulatory Filings
2026
Mar 17
Regulatory Filings
2026
Mar 17
M&A Activity
2026
Mar 3